205 related articles for article (PubMed ID: 30095613)
1. Altered long noncoding RNAs and survival outcomes in ovarian cancer: A systematic review and meta-analysis (PRISMA Compliant).
Ning L; Hu YC; Wang S; Lang JH
Medicine (Baltimore); 2018 Aug; 97(32):e11481. PubMed ID: 30095613
[TBL] [Abstract][Full Text] [Related]
2. The role of altered long noncoding RNAs in overall survival of ovarian cancer: A systematic review and meta-analysis.
Seyed Hosseini E; Alizadeh Zarei M; Haddad Kashani H; Milajerdi A; Zare Dehghanani Z; Hassani Bafrani H; Nikzad H
Pathol Res Pract; 2021 Mar; 219():153363. PubMed ID: 33621920
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis.
Luo P; Liu XF; Wang YC; Li ND; Liao SJ; Yu MX; Liang CZ; Tu JC
Oncotarget; 2017 Apr; 8(14):23927-23936. PubMed ID: 28118613
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNAs in bladder cancer prognosis: A meta-analysis.
Zhu W; Liu H; Wang X; Lu J; Yang W
Pathol Res Pract; 2019 Jun; 215(6):152429. PubMed ID: 31064722
[TBL] [Abstract][Full Text] [Related]
5. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant).
Seyed Hosseini E; Nikkhah A; Sotudeh A; Alizadeh Zarei M; Izadpanah F; Nikzad H; Haddad Kashani H
Cancer Cell Int; 2021 Aug; 21(1):447. PubMed ID: 34425840
[TBL] [Abstract][Full Text] [Related]
6. Integrated Analysis Reveals That Long Non-Coding RNA TUBA4B Can Be Used as a Prognostic Biomarker in Various Cancers.
Zhang T; Wu DM; Deng SH; Han R; Liu T; Li J; Xu Y
Cell Physiol Biochem; 2018; 49(2):530-544. PubMed ID: 30157490
[TBL] [Abstract][Full Text] [Related]
7. Abnormally expressed lncRNAs in the prognosis and clinicopathology of oesophageal cancer: a systematic review and meta-analysis.
Qian P; Xu Z; Chen H; Yue S; Lv Y
J Genet; 2020; 99():. PubMed ID: 32529986
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis.
Serghiou S; Kyriakopoulou A; Ioannidis JP
Mol Cancer; 2016 Jun; 15(1):50. PubMed ID: 27352941
[TBL] [Abstract][Full Text] [Related]
9. Aberrantly expressed long noncoding RNAs as potential prognostic biomarkers in newly diagnosed multiple myeloma: A systemic review and meta-analysis.
Qin J; Ke B; Liu T; Kong C; Li A; Fu H; Jin C
Cancer Med; 2023 Feb; 12(3):2199-2218. PubMed ID: 36057947
[TBL] [Abstract][Full Text] [Related]
10. TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
Zhong Y; Chen Z; Guo S; Liao X; Xie H; Zheng Y; Cai B; Huang P; Liu Y; Zhou Q; Liu Y; Huang W
Medicine (Baltimore); 2017 Nov; 96(46):e8583. PubMed ID: 29145271
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle mass as a prognostic indicator of outcomes in ovarian cancer: a systematic review and meta-analysis.
Rinninella E; Fagotti A; Cintoni M; Raoul P; Scaletta G; Scambia G; Gasbarrini A; Mele MC
Int J Gynecol Cancer; 2020 May; 30(5):654-663. PubMed ID: 32241875
[TBL] [Abstract][Full Text] [Related]
12. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of abnormally expressed lncRNAs in prostatic carcinoma: A systematic review and meta-analysis.
Wu XL; Zhang JW; Li BS; Peng SS; Yuan YQ
Medicine (Baltimore); 2017 Dec; 96(51):e9279. PubMed ID: 29390487
[TBL] [Abstract][Full Text] [Related]
14. Metallothioneins may be a potential prognostic biomarker for tumors: A Prisma-compliant meta-analysis.
Wang L; Xin F; Lin N; Wang Y; Liu X; Liu J
Medicine (Baltimore); 2018 Dec; 97(52):e13786. PubMed ID: 30593161
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: A systematic review and meta-analysis.
Masrour M; Khanmohammadi S; Fallahtafti P; Hashemi SM; Rezaei N
J Cell Mol Med; 2024 Feb; 28(3):e18109. PubMed ID: 38193829
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNAs (lncRNAs) as prognostic and diagnostic biomarkers in multiple myeloma: A systematic review and meta-analysis.
Mardani M; Rashedi S; Keykhaei M; Farrokhpour H; Azadnajafabad S; Tavolinejad H; Rezaei N
Pathol Res Pract; 2022 Jan; 229():153726. PubMed ID: 34942515
[TBL] [Abstract][Full Text] [Related]
17. The Role of Long Non-Coding RNAs in Ovarian Cancer.
Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
[TBL] [Abstract][Full Text] [Related]
18. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival of epithelial ovarian cancer: a systematic review and meta-analysis of observational studies.
Yang Z; Gu JH; Guo CS; Li XH; Yang WC
Oncotarget; 2017 Jul; 8(28):46414-46424. PubMed ID: 28423365
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
20. Does B7-H4 expression correlate with clinicopathologic characteristics and survival in ovarian cancer?: A systematic review and PRISMA-compliant meta-analysis.
Ye Y; Wang JJ; Li SL; Wang SY; Jing FH
Medicine (Baltimore); 2018 Aug; 97(32):e11821. PubMed ID: 30095655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
